Williams & Novak, LLC Abb Vie Inc. Transaction History

Williams & Novak, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$164.99 - $203.87 $23,263 - $28,745	141 Added 6.58%	2,285 $406 Million
Q3 2024 Oct 07, 2024	BUY	$163.84 - $199.33 $7,372 - $8,969	45 Added 2.14%	2,144 $423 Million
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $324,904 - $379,415	2,099 New	2,099 $360 Million

4,274

1.3B

16.1M

10.9M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $351B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Williams & Novak, LLC, based on Form 13F filings with the SEC.

Stay updated on Williams & Novak, LLC with notifications on news.